Elevation Oncology Inc (ELEV)
0.6139
-0.08
(-10.93%)
USD |
NASDAQ |
Nov 13, 16:00
0.6023
-0.01
(-1.89%)
After-Hours: 20:00
Elevation Oncology Market Cap: 36.29M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2024 | 40.74M |
| November 11, 2024 | 39.61M |
| November 08, 2024 | 38.42M |
| November 07, 2024 | 34.12M |
| November 06, 2024 | 32.52M |
| November 05, 2024 | 33.11M |
| November 04, 2024 | 30.90M |
| November 01, 2024 | 31.69M |
| October 31, 2024 | 33.95M |
| October 30, 2024 | 35.47M |
| October 29, 2024 | 35.06M |
| October 28, 2024 | 35.22M |
| October 25, 2024 | 34.41M |
| October 24, 2024 | 36.90M |
| October 23, 2024 | 35.51M |
| October 22, 2024 | 38.65M |
| October 21, 2024 | 34.60M |
| October 18, 2024 | 34.04M |
| October 17, 2024 | 32.59M |
| October 16, 2024 | 32.65M |
| October 15, 2024 | 30.68M |
| October 14, 2024 | 30.49M |
| October 11, 2024 | 30.30M |
| October 10, 2024 | 29.61M |
| October 09, 2024 | 30.56M |
| Date | Value |
|---|---|
| October 08, 2024 | 30.88M |
| October 07, 2024 | 32.07M |
| October 04, 2024 | 31.83M |
| October 03, 2024 | 30.78M |
| October 02, 2024 | 33.98M |
| October 01, 2024 | 33.13M |
| September 30, 2024 | 35.47M |
| September 27, 2024 | 34.87M |
| September 26, 2024 | 34.01M |
| September 25, 2024 | 34.16M |
| September 24, 2024 | 35.13M |
| September 23, 2024 | 34.00M |
| September 20, 2024 | 34.63M |
| September 19, 2024 | 35.45M |
| September 18, 2024 | 35.12M |
| September 17, 2024 | 35.67M |
| September 16, 2024 | 36.06M |
| September 13, 2024 | 35.98M |
| September 12, 2024 | 36.06M |
| September 11, 2024 | 35.67M |
| September 10, 2024 | 36.04M |
| September 09, 2024 | 37.24M |
| September 06, 2024 | 36.94M |
| September 05, 2024 | 38.42M |
| September 04, 2024 | 39.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.12M
Minimum
Nov 10 2023
367.22M
Maximum
Jul 12 2021
92.05M
Average
58.25M
Median
Mar 15 2022
Market Cap Benchmarks
| CEL-SCI Corp | 38.75M |
| AIM ImmunoTech Inc | 14.79M |
| IGC Pharma Inc | 27.30M |
| NovaBay Pharmaceuticals Inc | 3.481M |
| Protalix BioTherapeutics Inc | 90.46M |
Market Cap Related Metrics
| Price to Book Value | 0.5233 |
| Price | 0.6139 |
| Earnings Yield | -135.2% |